The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
Phones:
+7 (495) 482-4118
+7 (495) 482-4329
  • Toll-free number for subscriptions:
    +8 800 250-18-12
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Volchenko N.N.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Lavrova A.M.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Malushkova M.E.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Goeva N.S.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Lung adenocarcinoma combined with neuroendocrine «tumorlets»

Authors:

Volchenko N.N., Lavrova A.M., Malushkova M.E., Goeva N.S.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2026;15(1): 47‑51

DOI: 10.17116/onkolog20261501147

Read: 459 times

Contact the author
Table of contents

LUNG ADENOCARCINOMA COMBINED WITH NEUROENDOCRINE «TUMORLETS»
LUNG ADENOCARCINOMA COMBINED WITH NEUROENDOCRINE «TUMORLETS»

To cite this article:

Volchenko NN, Lavrova AM, Malushkova ME, Goeva NS. Lung adenocarcinoma combined with neuroendocrine «tumorlets». P.A. Herzen Journal of Oncology. 2026;15(1):47‑51. (In Russ.)
https://doi.org/10.17116/onkolog20261501147

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Video-assisted mediastinal lymphadenectomy in the treatment stra­tegy of patients with non-small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2025;(5):13-18
Fluorescent in situ-hybridization (FISH) in onco­logy. P.A. Herzen Journal of Onco­logy. 2025;(6):88-93
Morphological examination of surgical mate­rial of primary lung cancer after neoadjuvant therapy: reco­mmendations and lite­rature review. Russian Journal of Archive of Pathology. 2025;(4):40-46
Features of lung cancer carcinogenesis invo­lving cancer stem cells in COVID-19. Effe­cts of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;(5):65-73
Pulmonary artery surgery in thoracic onco­logy. Piro­gov Russian Journal of Surgery. 2025;(10):24-30
Prediction of mediastinal nodal meta­stases based on multivariate analysis of VAMLA resu­lts in non-small cell lung cancer patients. Piro­gov Russian Journal of Surgery. 2025;(10):38-46
Alte­rations in proprotein convertase genes’ expression during mali­gnization of human lung cells have a limi­ted set of scenarios. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):121-128
Resu­lts, problems and prospects of photodynamic therapy in thoracic onco­logy based on a series of obse­rvations. Endo­scopic Surgery. 2025;(6):21-26
Lung cancer screening as a part of the preventive medi­cal examination of certain groups of the adult popu­lation. Methodological reco­mmendations. Russian Journal of Preventive Medi­cine. 2026;(1-2):9-37
Abstract:

Neuroendocrine tumors are a group of malignant neoplasms that differs from each other in morphology, immunophenotype, molecular genetic profiles, biological and clinical behavior. Neuroendocrine tumors more frequently occur in the gastrointestinal tract and the respiratory system, predominantly in lungs. According to the classification of the World Health Organization, there are neuroendocrine tumors with low and intermediate malignant potential (typical and atypical carcinoid), with high malignant potential (small cell and large cell carcinoma) in lungs. Neuroendocrine cell hyperplasia and neuroendocrine «tumorlets» are preinvasive neuroendocrine lung lesions. We describe 5 cases of invasive lung adenocarcinomas combined with neuroendocrine «tumorlets», which were identified during pathological research of surgical material.

Keywords:

lung cancer
neuroendocrine «tumorlets»

Authors:

Volchenko N.N.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Lavrova A.M.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Malushkova M.E.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Goeva N.S.

P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre

Received:

16.02.2025

Accepted:

25.06.2025

Close metadata

References:

  1. Sousa D, Rocha F, Baptista B, Horta AB. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia With Progression to Neuroendocrine Tumor. Cureus. 2021;13(2):2-7.  https://doi.org/10.7759/cureus.13297
  2. Benson REC, Rosado-de-Christenson ML, Martínez-Jiménez S, et al. Spectrum of pulmonary neuroendocrine proliferations and neoplasms. Radiographics. 2013;33(6):1631-1649. https://doi.org/10.1148/rg.336135506
  3. WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 5). https://publications.iarc.fr/595
  4. Trucco GV, Righi L, Volante M, Papotti M. Updates on lung neuroendocrine neoplasm classification. Histopathology. 2024;84(1):67-85.  https://doi.org/10.1111/his.15058
  5. Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol Elsevier Inc. 2022;17(3): 362-387.  https://doi.org/10.1016/j.jtho.2021.11.003
  6. Tchercansky AN, Buero A, Auvieux R, et al. Incidental pulmonary carcinoid tumorlet associated with lung cancer. Medicina (B Aires). 2022;82(2):297-299. 
  7. Patané K, Lucchelli J, Fernandez M, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia/tumorlets. Medicina (B. Aires). 2022;82(1):154-158. 
  8. Koo CW, Baliff JP, Torigian DA, et al. Spectrum of pulmonary neuroendocrine cell proliferation: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids. Am J Roentgenol. 2010;195(3):661-668.  https://doi.org/10.2214/AJR.09.3811
  9. Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease. J Thorac Oncol. 2017;12(3):425-436.  https://doi.org/10.1016/j.jtho.2016.11.2222
  10. Lococo F, Galeone C, Sacchettini C, et al, AIRTUM working group contributors. Second malignancy risk in patients with bronchopulmonary carcinoids: Epidemiological results from Italian Network of Cancer Registries. Tumori. 2017;103(2):e15-e20.  https://doi.org/10.5301/tj.5000598
  11. Panek I, Liczek M, Rakoczy I, et al. Coexistence of Pulmonary Fibrosis and Proliferation of Pulmonary Neuroendocrine Cells Forming Tumorlet. Wiad Lek. 2021;74(7):1767-1769. https://doi.org/10.36740/WLek202107136
  12. Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab Investig. 2006;86(5):425-444.  https://doi.org/10.1038/labinvest.3700412
  13. Han X, Wang Y, Wei H, et al. Multifocal neuroendocrine cell hyperplasia accompanied by tumorlet formation and pulmonary sclerosing pneumocytoma: A case report. World J Clin Cases. 2020;8(16):3583-3590. https://doi.org/10.12998/wjcc.v8.i16.3583
  14. Gosney JR, Williams IJ, Dodson AR, Foster CS. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology. 2011;59(4):751-762.  https://doi.org/10.1111/j.1365-2559.2011.03992.x
  15. Leal FF, Rodríguez ÁS, Sarasúa LG. Hiperplasia difusa idiopática de células neuroendocrinas pulmonares: importancia de la TC espiratoria. Med Clin (Barc). 2016;147(1):e3-e4.  https://doi.org/10.1016/j.medcli.2016.01.023
  16. Sun TY, Hwang G, Pancirer D, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour. Eur Respir J. 2022;59(1):1-5.  https://doi.org/10.1183/13993003.01058-2021
  17. Mireskandari M, Abdirad A, Zhang Q, et al. Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung. Pathol Res Pract Elsevier GmbH. 2013;209(9):578-584.  https://doi.org/10.1016/j.prp.2013.06.019
  18. Delektorskaya VV. Neuroendocrine tumors of the lung: the current classification and pathology diagnosis algorithm. Adv Mol Oncol. 2017;4(2):46-58. (In Russ.). https://doi.org/10.17650/2313-805X-2017-4-2-46-58
  19. Whitwell F. Tumorlets of the Lung. J Path Bact. 1955;70(2):529-541.  https://doi.org/10.1002/path.1700700231
  20. Kallianos A, Velentza L, Zarogoulidis P, et al. Progressive dyspnea due to pulmonary carcinoid tumorlets. Respir Med Case Reports. 2017;21:84-85.  https://doi.org/10.1016/j.rmcr.2017.03.024
  21. Wang J, Ren S, Liu Y, et al. Carcinoid tumorlets co-existing with chronic pulmonary inflammatory processes: Imaging findings and histological appearances. Med Sci Monit. 2020;26:1-8.  https://doi.org/10.12659/MSM.926014
  22. He P, Gu X, Wu Q, et al. Pulmonary carcinoid tumorlet without underlying lung disease: Analysis of its relationship to fibrosis. J Thorac Dis. 2012;4(6):655-658.  https://doi.org/10.3978/j.issn.2072-1439.2012.06.11
  23. Yagyu K, Miyamoto A, Matsushita H, Okimora A. A case of lung tumorlets secondary to pulmonary hypoplasia with recurrent haemoptysis. Respirol Case Reports. 2018;6(8):1-4.  https://doi.org/10.1002/rcr2.373
  24. Chien C, Lin W, Chang J, et al. Synchronous Caplan’s syndrome, pulmonary adenocarcinoma and carcinoid tumorlet. Pathol Int. 2020;70(11):906-908.  https://doi.org/10.1111/pin.13003
  25. Gorospe L, Muñoz-Molina GM, Farfán-Leal FE, et al. Association of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with lung adenocarcinoma: A radiologist’s perspective. Lung Cancer. 2017; 110(June):77-79.  https://doi.org/10.1016/j.lungcan.2017.06.010
  26. Warth A, Herpel E, Schmähl A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: A case report. J Med Case Rep. 2008;2:1-3.  https://doi.org/10.1186/1752-1947-2-21
  27. Inomata S, Matsumura Y, Kobayashi Y, et al. Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report. Thorac Cancer. 2022;13(21):3076-3079. https://doi.org/10.1111/1759-7714.14662
  28. Czapiewski P, Majewska H, Tomaszewski D, Biernat W. Coexistence of tumorlet and marginal zone B-cell lymphoma in the lung. Pathol Res Pract Elsevier. 2010;206(7):508-510.  https://doi.org/10.1016/j.prp.2010.01.004
  29. Omid Savari O, Hastings H, Rayes R, Tomashefski Jr JF. Neuroendocrine Neoplasia in Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) of the Lung: A Case Report and Immunohistochemistry Analysis of Eight Pulmonary MALT Lymphomas. Int J Surg Pathol. 2018;26(7):660-663.  https://doi.org/10.1177/1066896918769745
  30. Benito-Martínez E, Galeano-Valle F, González A, et al. Ectopic ACTH syndrome with association of multiple pulmonary sclerosing pneumocytomas and multiple carcinoid tumorlets. J Endocr Soc. 2019;3(5):937-942.  https://doi.org/10.1210/js.2018-00334
  31. Wang Y, He Q, Shi W, et al. A mixture of carcinoid tumors, extensive neuroendocrine proliferation, and multiple pulmonary sclerosing hemangiomas. World J Surg Oncol. 2014;12(1):1-6.  https://doi.org/10.1186/1477-7819-12-209
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.